BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/13/2024 3:22:17 AM | Browse: 309 | Download: 956
Publication Name World Journal of Gastroenterology
Manuscript ID 99273
Country India
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease
Manuscript Source Invited Manuscript
All Author List Siva Sundara Kumar Durairajan, Abhay Kumar Singh and Ashok Iyaswamy
ORCID
Author(s) ORCID Number
Siva Sundara Kumar Durairajan http://orcid.org/0000-0001-7376-7163
Funding Agency and Grant Number
Corresponding Author Siva Sundara Kumar Durairajan, MSc, PhD, Associate Professor, Department of Microbiology, School of Life Sciences, Central University of Tamil Nadu, Neelakudi, Tiruvarur 610005, India. d.sivasundarakumar@cutn.ac.in
Key Words Alcoholic liver disease; Peroxisome proliferator-activated receptors; Peroxisome proliferator-activated receptors agonists; Liver fibrosis; Inflammation; Metabolic regulation; Hepatoprotection
Core Tip Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors, including PPARα, PPARγ, and PPARβ/δ. They regulate vital factors in the development of alcoholic liver disease (ALD), like lipid metabolism, inflammation, and fibrosis. PPAR agonists have the potential to manage ALD. In recent preclinical and clinical trials, PPAR agonists have revealed their potency to eliminate liver steatosis, improve insulin receptor sensitivity, and diminish inflammation and fibrosis. However, to confirm their effectiveness and reveal side effects, larger clinical trials in ALD must be conducted. This article, therefore, raises the need for further study and debate on the application of PPAR agonists for ALD management.
Publish Date 2024-09-13 03:22
Citation

Durairajan SSK, Singh AK, Iyaswamy A. Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease. World J Gastroenterol 2024; 30(35): 3965-3971

URL https://www.wjgnet.com/1007-9327/full/v30/i35/3965.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i35.3965
Full Article (PDF) WJG-30-3965-with-cover.pdf